Showing results (291-300 of 323) with videos related to

Sort By:
Pageof 33
Alimentary Pharmacology & Therapeutics|May 18, 2012
Review article: current treatment options and management of functional dyspepsiaB E Lacy, N J Talley, G R Locke, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 27, 2008
Access to specialist gastroenterology care in Canada: comparison of wait times and consensus targetsD Leddin, D Armstrong, A Ng Barkun, et al.
The American Journal of Gastroenterology|February 3, 1998
Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistanceS Veldhuyzen van Zanten, R H Hunt, A Cockeram, et al.
Scandinavian Journal of Gastroenterology|January 1, 1980
Histamine H2 receptors and intrinsic factor secretionP C Sharpe, J G Mills, M A Horton, et al.
Journal of Clinical Microbiology|September 1, 1989
Optimization of a medium for the rapid urease test for detection of Campylobacter pylori in gastric antral biopsiesJ Goldie, S J Veldhuyzen van Zanten, S Jalali, et al.
Alimentary Pharmacology & Therapeutics|January 22, 2003
Complementary studies of the gastrointestinal safety of the cyclo-oxygenase-2-selective inhibitor etoricoxibR H Hunt, S Harper, P Callegari, et al.
Digestive Diseases and Sciences|February 1, 1995
Optimizing acid suppression for treatment of acid-related diseasesR H Hunt, C Cederberg, J Dent, et al.
The American Journal of Gastroenterology|November 1, 1987
Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseasesR T Jenkins, D B Jones, R L Goodacre, et al.
Agents and Actions|January 1, 1993
Effects of chronic NSAIDs on gastric mucosal injury related to mucosal prostanoids, and plasma drug concentrations in human volunteersK D Rainsford, C James, D M Johnson, et al.
The American Journal of Medicine|September 7, 2000
A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjectsR H Hunt, B Bowen, E R Mortensen, et al.
Pageof 33